Occurrence, virulence profile and antimicrobial resistance of Aeromonas sp. from vegetables
Some species of Aeromonas cause gastroenteritis, meningitis, endocarditis, arthritis, osteomyelitis, skin infections and other disorders and is considered an emergent pathogen to public health. Given that significance, this project aimed to evaluate: i) the occurrence of potentially pathogenic Aeromonas sp. in hydroponic, conventionally and minimally processed vegetables marketed in the city of Campinas-SP; ii) the pathogenic potential of the isolates by detection of genes encoding virulence factors for gastroenteritis (aer encoding aerolysin; hlyA encoding hemolysin, and enterotoxins genes act, alt and ast, encoding Act, Alt and Ast, respectively) and iii) the susceptibility of the isolates to gentamicin, tetraciclyn ciproflocaxin, chloramphenicol, cefepime, clindamycin and moxifloxacin. A total of 103 samples of vegetable were analyzed. The occurrences in conventional, hydroponics and minimally processed samples were 56.9% (33/58), 33.3% (5/15) and 56.7% (17/30), with counts ranging from <102 to 3.4 x 106 CFU.g-1, <102 to 3.6 x 105 CFU.g-1 and <102 to 2.3 x 104 CFU.g-1 respectively. Antimicrobial resistance test revealed that ciprofloxacin, chloramphenicol, gentamicin and moxifloxacin were the most effective against Aeromonas sp., while clindamycin was the least effective with 97.46% (77/79) of isolates resistant. The resistance to clindamicyn and cefepime and clindamicyn and tetracycline was observed in 5,06% (4/79) of the isolates. The genotypic profile of the isolates was variable. Virulence gene alt was the most common among the isolates, and was detected in 68,3% (54/79). Genes act, ast, hlyA and aer were found in 34,2% (27/79), 56,9% (45/79), 40,5% (32/79) and 49,4% (39/79), respectively. These results show the virulent potential of Aeromonas sp. isolates from vegetables. In addition, emphasize the importance of controlled use of antimicrobials in order to avoid the increase of Aeromonas sp. antimicrobial resistance.